Key result
Trandolapril or losartan attenuates volume overload-induced cardiac hypertrophy and ECM alterations in rats.
Why the study?
The authors aimed to explore the impact of volume overload due to aorto-caval fistula on connexin-43 and extracellular matrix, as well as the effect of renin-angiotensin blockade.
Does trandolapril or losartan improve cardiac connexin-43 and extracellular matrix alterations in normotensive and hypertensive rats with volume overload-induced heart failure?
Does trandolapril or losartan improve cardiac connexin-43 and extracellular matrix alterations in normotensive and hypertensive rats with volume overload-induced heart failure?
Trandolapril and losartan attenuate volume overload-induced extracellular matrix remodeling and connexin-43 downregulation in a rat model of heart failure, suggesting pleiotropic antiarrhythmic potential.
Answers are grounded in this paper and cite their sources.
RAS blockade attenuates Cx43/ECM alterations in volume-overload rat HF; leaves open relevance to human arrhythmogenesis or therapy.
Heart failure (HF) is life-threatening disease due to electro-mechanical dysfunction associated with hemodynamic overload, while alterations of extracellular matrix (ECM) along with perturbed connexin-43 (Cx43) might be key factors involved. We aimed to explore an impact of volume overload due to aorto-caval fistula (ACF) on Cx43 and ECM as well as effect of renin-angiotensin blockade. Hypertensive Ren-2 transgenic rats (TGR) and normotensive Hannover Sprague–Dawley rats (HSD) that underwent ACF were treated for 15-weeks with Trandolapril or Losartan. Blood serum and heart tissue samples of the right (RV) and left ventricles (LV) were used for analyses. ACF-HF increased RV and LV mass in HSD and to lesser extent in TGR, while treatment attenuated it and normalized serum ANP and TBARS. Cx43 protein and its ser368 variant along PKCε were lower in TGR vs HSD and suppressed in both rat strains due to ACF but prevented more by trandolapril. Pro-hypertrophic PKCδ, collagen I and hydroxyproline were elevated in TGR and increased due to ACF in both rat strains. While Smad2/3 and MMP2 levels were lower in TGR vs HSD and reduced due to ACF in both strains. Findings point out the strain-related differences in response to volume overload. While disorders of Cx43 and ECM signalling may contribute not only to HF but also to malignant arrhythmia risk. There is benefit of treatment with trandolapril and losartan indicating their pleitropic antiarrhytmic potential. It may provide novel input to therapy.
No takes yet. Share an insight, caveat, or question.
Krátký et al. (2023) studied Heart failure due to volume overload (n=80). Trandolapril or Losartan vs. Untreated rats with aortocaval fistula was evaluated on Cardiac connexin-43 protein levels and extracellular matrix alterations. Treatment with trandolapril or losartan significantly attenuated volume overload-induced cardiac hypertrophy and mitigated alterations in connexin-43 and extracellular matrix in both normotensive and hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: